Peer-reviewedCC BYCells
Protein Tyrosine Phosphatases in Cancer: From Oncogenic Drivers to Therapeutic Targets
5 affiliations
- 1Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06510, USA (A.K.)
- 2Department of Biochemistry and Molecular Biophysics, Columbia University Irving Medical Center, New York, NY 10032, USA;
- 3Centre for Molecular and Nanomedical Sciences, International Research Centre, Sathyabama Institute of Science and Technology (Deemed to Be University), Chennai 600119, Tamil Nadu, India;
- 4Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, 779 00 Olomouc, Czech Republic;
- 5Department of Pathology, University of Chicago, Chicago, IL 60637, USA
Related
- PLD1-driven oncogenic secretion creates a therapeutic vulnerability in chromosome 3q–amplified NSCLC
- Protein tyrosine kinases in dendritic cell-mediated anti-cancer immunity
- A novel adenovirus 19K/IX protein enhances infection by attenuating proteasomal degradation of tyrosine-ubiquitinated capsid protein IX
- Recent Advances in Protein Tyrosine Sulfation and Its Emerging Roles in Human Diseases
- Acute lung injury: an integrated view of molecular drivers, immune dysregulation, and emerging therapeutic strategies
BibTeX
@article{perla2026protein,
title = {{Protein Tyrosine Phosphatases in Cancer: From Oncogenic Drivers to Therapeutic Targets}},
author = {Sravan Perla and Jonathan Pascale and Matthew Liu and Ashish Kumar and Sivaraman Kuppuswamy and Charanraj Goud Alladi and Vishnu Amaram Samara},
journal = {Cells},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13664233},
note = {CC BY},
}
RIS
TY - JOUR
TI - Protein Tyrosine Phosphatases in Cancer: From Oncogenic Drivers to Therapeutic Targets
AU - Sravan Perla
AU - Jonathan Pascale
AU - Matthew Liu
AU - Ashish Kumar
AU - Sivaraman Kuppuswamy
AU - Charanraj Goud Alladi
AU - Vishnu Amaram Samara
PY - 2026
DA - 2026/09/29
JO - Cells
UR - https://europepmc.org/article/PMC/PMC13664233
SN - 2073-4409
ER -